Monocyclic β-lactam compound for treating bacterial infection

US11459323B2 · kind B2 · utility

Assignee

• Medshine Discovery Inc. · CN

Inventors

• Lianghu Gu · Shanghai, CN
• Wei LUO · Shanghai, CN
• Zhigang Huang · Longbeilingcun, CN
• Charles Z. Ding · San Mateo, US
• Cheng LI · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jan 29, 2019
• Grant date: Oct 4, 2022
• Expiry date: May 27, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are a class of new monocyclic β-lactam compounds, an isomer thereof or pharmaceutically acceptable salts thereof, and a pharmaceutical composition comprising the compounds, and the use of same in preparing drugs for treating diseases associated with bacterial infection. Specifically disclosed are the compounds as shown in formula (I′) and formula (II′), isomers thereof or pharmaceutically acceptable salts thereof.